A209 SICD Gen 2,A219 SICD MRI
BOSTON SCIENTIFIC CORPORATION · Decision date Oct 22, 2025
What did the FDA decide?
FDA records P110042/S206 as a supplement to PMA P110042, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 22, 2025.
FDA approval order statement
to extend the time that solder paste can remain on the stencil before cleaning when building pulse generator printed circuit board assemblies
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 22, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P110042/S206
- Regulatory pathway
- PMA supplement
- Applicant
- BOSTON SCIENTIFIC CORPORATION
- Product code
- LWS
- Decision code
- OK30
- Decision date
- Oct 22, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Applicant
- Boston Scientific Corporation
- Product code
- LWS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P110042. Subsequent supplements may change the device or its indications.
FDA decision timeline
P110042 · Original PMA
SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR (S-ICD) SYSTEM
P110042/S205 · Related supplement
SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR (S-ICD) SYSTEM
P110042/S206 received
Application receipt date recorded by FDA.
P110042/S206 · FDA decision
30-Day Notice
P110042/S204 · Related supplement
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD): EMBLEM S-ICD Model A209 and EMBLEM MRI S-ICD Model A219
P110042/S208 · Related supplement
EMBLEM S-ICD/ model 3501
P110042/S203 · Related supplement
EMBLEM S-ICD Electrode (Lead)
P110042/S207 · Related supplement
EMBLEM S-ICD subcutaneous electrode/lead
P110042/S209 · Related supplement
EMBLEM S-ICD subcutaneous electrode/lead
P110042/S212 · Related supplement
EMBLEM, EMBLEM MRI
P110042/S213 · Related supplement
S-ICD Electrode Model: 3501
P110042/S211 · Related supplement
EMBLEM S-ICD
P110042/S214 · Related supplement
Emblem S-ICD (A209); Emblem MRI S-ICD (A219)
P110042/S210 · Related supplement
EMBLEM S-ICD Electrode (Lead) Model 3501
P110042/S215 · Related supplement
S-ICD EMBLEM GEN 2 (A209); S-ICD EMBLEM MRI (A219)
P110042/S216 · Related supplement
EMBLEM Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) high voltage (HV) Capacitor
Timeline entries are records held by MedtechLedger for P110042. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P110042
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA | |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corporation
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P110042/S206
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






